Back
Serina Therapeutics Vs. Recursion Pharmaceuticals Industry Stock Comparison
Sell
33
SER
Serina Therapeutics
Last Price:
4.80
Seasonality Move:
3.68%
Buy
62
RXRX
Recursion Pharmaceuticals
Last Price:
7.56
Seasonality Move:
-15.32%
Sell
33
Serina Therapeutics (SER)
is a Sell
Is Serina Therapeutics a Buy, Sell or Hold?
- The current Serina Therapeutics [SER] share price is $4.76. The Score for SER is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- SER is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $7.57. The Score for RXRX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- RXRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SER Stock Price Chart
What is Serina Therapeutics's stock price today?
-
The Serina Therapeutics share price today is $4.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SER is experiencing selling pressure, which indicates risk of future bearish movement.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $7.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight buying pressure.
SER Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 41.28 | Sell |
Chaikin Money Flow: | -13283 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.68 - 5.44) | Sell |
Bollinger Bands (100): | (5.52 - 8.28) | Sell |
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 56.14 | Buy |
Chaikin Money Flow: | 440743 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.14 - 7.6) | Buy |
Bollinger Bands (100): | (6.2 - 7.5) | Buy |
SER Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.34 | Sell |
20-day SMA: | 5.09 | Sell |
50-day SMA: | 6.04 | Sell |
200-day SMA: | 8.75 | Sell |
8-day EMA: | 5.2 | Sell |
20-day EMA: | 5.3 | Sell |
50-day EMA: | 5.89 | Sell |
200-day EMA: | 9.06 | Sell |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.46 | Buy |
20-day SMA: | 6.76 | Buy |
50-day SMA: | 6.68 | Buy |
200-day SMA: | 8.02 | Sell |
8-day EMA: | 7.4 | Buy |
20-day EMA: | 7.03 | Buy |
50-day EMA: | 6.86 | Buy |
200-day EMA: | 7.61 | Sell |
Serina Therapeutics Earnings Growth & SER Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Serina Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Recursion Pharmaceuticals Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |